Hydroxycitric acid tripotassium hydrate, CAS [[6100-05-6]]

Artikelnummer: BYT-ORB1309565
Artikelname: Hydroxycitric acid tripotassium hydrate, CAS [[6100-05-6]]
Artikelnummer: BYT-ORB1309565
Hersteller Artikelnummer: orb1309565
Alternativnummer: BYT-ORB1309565-1,BYT-ORB1309565-10,BYT-ORB1309565-5,BYT-ORB1309565-500
Hersteller: Biorbyt
Kategorie: Biochemikalien
Alternative Synonym: ACLY, 1534146, ATPCitrateLyase, ATP, ATP Citrate Lyase, ATP citrate lyase, anti-inflammation, antioxidation, Bacterial, cleavage, CaOx, Citrate, inhibit, extramitochondrial, Hypoxia-inducible factors, Hydroxycitric acid tripotassium, Hydroxycitric acid tripotassium hydrate, Hydroxycitric acid tripotassium Hydrate, Inhibitor, HIFs, HIFProlylHydroxylase, HIF, HIF ProlylHydroxylase, HIF Prolyl-Hydroxylase, HIF-PH, HIF-1alpha, HIF/HIF ProlylHydroxylase, HIF/HIF Prolyl-Hydroxylase, HIF/HIFProlylHydroxylase, Potassium citrate, Potassium Citrate, Potassium citrate Monohydrate, Potassium citrate monohydrate, stones, safety
Potassium citrate monohydrate, a derivative of citric acid and key component of Garcinia cambogia, acts as an ATP-citrate lyase inhibitor. It is applied in research exploring nephrolithiasis prevention, metabolic studies for weight management, and investigations into its HIF-inhibitory, antioxidant, and anti-inflammatory properties in cellular and animal models.
Molekulargewicht: 324.41
Reinheit: 99.85% (May vary between batches)
CAS Nummer: [6100-05-6]
Formel: C6H7K3O8
Target-Kategorie: Apoptosis,ATP Citrate Lyase,HIF/HIF Prolyl-Hydroxylase,Antibacterial,Endogenous Metabolite,HIF
Anwendungsbeschreibung: Solubility: DMSO:2.49 mg/mL (7.68 mM)